Clinical Investigation| Volume 364, ISSUE 3, P304-308, September 2022

Cannabis use is associated with prevalent coronary artery disease



      Cannabis is associated with risk of acute coronary syndrome in observational studies. However, its association with prevalent coronary artery disease (CAD) remains unclear. We hypothesized that cannabis use is associated with prevalent CAD.


      This analysis included 12,543 participants (age 39.3 ± 11.6 years, 48.8% male, 35.3% Caucasians) from The National Health and Nutrition Examination Survey (NHANES). Cannabis use was self-reported. Prevalent CAD was defined by physician diagnosis. The association between cannabis use and CAD was tested for using multivariable logistic regression.


      About 53.1% (n = 6,650) of participants were ever cannabis users and 1.1% (n = 137) had prevalent CAD. Ever (versus never) cannabis users had 90% increased odds of CAD [OR (95% CI): 1.90 (1.24 - 2.93), p = 0.003]. Those who had used cannabis at least once per month for at least one year had 68% increased odds of CAD [OR (95% CI): 1.68 (1.02-2.77), p = 0.04]. Current cannabis users had near 98% increased odds of CAD [OR (95% CI): 1.98 (1.11 – 3.54), p = 0.02]. Similar results were seen with heavy cannabis users [OR (95% CI): 1.99 (1.02 – 3.89), p = 0.045]. These results were consistent in subgroups stratified by race, gender, hypertension, obesity, COPD, hyperlipidemia, tobacco smoking status, and diabetes.


      Cannabis use is associated with prevalent CAD. This finding emphasizes the potential harmful effects of cannabis use on cardiovascular health and highlights the need for further research as it becomes more accepted at both a national and global level.

      Key Indexing Terms

      To read this article in full you will need to make a payment

      Purchase one-time access:

      Academic & Personal: 24 hour online accessCorporate R&D Professionals: 24 hour online access
      One-time access price info
      • For academic or personal research use, select 'Academic and Personal'
      • For corporate R&D use, select 'Corporate R&D Professionals'


      Subscribe to The American Journal of the Medical Sciences
      Already a print subscriber? Claim online access
      Already an online subscriber? Sign in
      Institutional Access: Sign in to ScienceDirect


      1. The CBHSQ Report. Rockville, MD; 2013.

      2. The Health Effects of Cannabis and Cannabinoids: The Current State of Evidence and Recommendations for Research. The National Academies Collection: Reports funded by National Institutes of Health series. Washington, DC; 2017.

        • Wilkinson ST
        • Yarnell S
        • Radhakrishnan R
        • Ball SA
        • D'Souza DC
        Marijuana legalization: impact on physicians and public health.
        Annu Rev Med. 2016; 67: 453-466
        • Cerda M
        • Wall M
        • Keyes KM
        • Galea S
        • Hasin D.
        Medical marijuana laws in 50 states: investigating the relationship between state legalization of medical marijuana and marijuana use, abuse and dependence.
        Drug Alcohol Depend. 2012; 120: 22-27
        • Patel RS
        • Manocha P
        • Patel J
        • Patel R
        • Tankersley WE.
        Cannabis use is an independent predictor for acute myocardial infarction related hospitalization in younger population.
        J Adolesc Health. 2020; 66: 79-85
        • Chami T
        • Kim CH.
        Cannabis abuse and elevated risk of myocardial infarction in the young: a population-based study.
        Mayo Clin Proc. 2019; 94: 1647-1649
        • Richards JR
        • Bing ML
        • Moulin AK
        • et al.
        Cannabis use and acute coronary syndrome.
        Clin Toxicol (Phila). 2019; 57: 831-841
        • Henry JA
        • Oldfield WL
        • Kon OM.
        Comparing cannabis with tobacco.
        BMJ. 2003; 326: 942-943
      3. Roy A, Rawal I, Jabbour S, et al. Tobacco and cardiovascular disease: a summary of evidence. In: rd, Prabhakaran D, Anand S, et al., editors. Cardiovascular, Respiratory, and Related Disorders. Washington, DC; 2017.

        • Rajavashisth TB
        • Shaheen M
        • Norris KC
        • et al.
        Decreased prevalence of diabetes in marijuana users: cross-sectional data from the National Health and Nutrition Examination Survey (NHANES) III.
        BMJ Open. 2012; 2e000494
        • Smit E
        • Crespo CJ.
        Dietary intake and nutritional status of US adult marijuana users: results from the third national health and nutrition examination survey.
        Public Health Nutr. 2001; 4: 781-786
        • Whelton PK
        • Carey RM
        • Aronow WS
        • et al.
        2017 ACC/AHA/AAPA/ABC/ACPM/AGS/APhA/ASH/ASPC/NMA/PCNA guideline for the prevention, detection, evaluation, and management of high blood pressure in adults: executive summary: a report of the American college of cardiology/American heart association task force on clinical practice guidelines.
        Hypertension. 2018; 71: 1269-1324
        • Budney AJ
        • Roffman R
        • Stephens RS
        • Walker D.
        Marijuana dependence and its treatment.
        Addict Sci Clin Pract. 2007; 4: 4-16
        • Kaufman TM
        • Fazio S
        • Shapiro MD.
        Brief commentary: marijuana and cardiovascular disease-what should we tell patients?.
        Ann Intern Med. 2019; 170: 119-120
        • Franz CA
        • Frishman WH.
        Marijuana use and cardiovascular disease.
        Cardiol Rev. 2016; 24: 158-162
        • Reis JP
        • Auer R
        • Bancks MP
        • et al.
        Cumulative lifetime marijuana use and incident cardiovascular disease in middle age: the coronary artery risk development in young adults (CARDIA) study.
        Am J Public Health. 2017; 107: 601-606
        • Richards JR
        • Singh GD
        • Parikh AK
        • Venugopal S.
        Acute coronary syndrome after cannabis use: correlation with quantitative toxicology testing.
        Am J Emerg Med. 2019; 37: 1007.e1-1007.e4
        • Burt JR
        • Agha AM
        • Yacoub B
        • Zahergivar A
        • Pepe J.
        Marijuana use and coronary artery disease in young adults.
        PLoS One. 2020; 15e0228326
        • ElSohly MA
        • Mehmedic Z
        • Foster S
        • Gon C
        • Chandra S
        • Church JC.
        Changes in cannabis potency over the last 2 decades (1995-2014): analysis of current data in the United States.
        Biol Psychiatry. 2016; 79: 613-619